324 related articles for article (PubMed ID: 16687221)
1. Preparation of silymarin proliposome: a new way to increase oral bioavailability of silymarin in beagle dogs.
Yan-yu X; Yun-mei S; Zhi-peng C; Qi-neng P
Int J Pharm; 2006 Aug; 319(1-2):162-8. PubMed ID: 16687221
[TBL] [Abstract][Full Text] [Related]
2. [Preparation of silymarin proliposomes and its pharmacokinetics in rats].
Xiao YY; Song YM; Chen ZP; Ping QN
Yao Xue Xue Bao; 2005 Aug; 40(8):758-63. PubMed ID: 16268514
[TBL] [Abstract][Full Text] [Related]
3. The preparation of silybin-phospholipid complex and the study on its pharmacokinetics in rats.
Yanyu X; Yunmei S; Zhipeng C; Qineng P
Int J Pharm; 2006 Jan; 307(1):77-82. PubMed ID: 16300915
[TBL] [Abstract][Full Text] [Related]
4. Oil based nanocarrier for improved oral delivery of silymarin: In vitro and in vivo studies.
Parveen R; Baboota S; Ali J; Ahuja A; Vasudev SS; Ahmad S
Int J Pharm; 2011 Jul; 413(1-2):245-53. PubMed ID: 21549187
[TBL] [Abstract][Full Text] [Related]
5. [Preparation of self-assemble nobiletin proliposomes and its pharmacokinetics in rats].
Lin W; Yao J; Zhou JP
Yao Xue Xue Bao; 2009 Feb; 44(2):192-6. PubMed ID: 19408692
[TBL] [Abstract][Full Text] [Related]
6. Optimized preparation of vinpocetine proliposomes by a novel method and in vivo evaluation of its pharmacokinetics in New Zealand rabbits.
Xu H; He L; Nie S; Guan J; Zhang X; Yang X; Pan W
J Control Release; 2009 Nov; 140(1):61-8. PubMed ID: 19651165
[TBL] [Abstract][Full Text] [Related]
7. [Effect of particle size on oral absorption of silymarin-loaded solid lipid nanoparticles].
He J; Hou SX; Feng JF; Cai BQ
Zhongguo Zhong Yao Za Zhi; 2005 Nov; 30(21):1651-3. PubMed ID: 16400939
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of the in-vitro dissolution and in-vivo oral bioavailability of silymarin from liquid-filled hard gelatin capsules of semisolid dispersion using Gelucire 44/14 as a carrier.
Hussein A; El-Menshawe S; Afouna M
Pharmazie; 2012 Mar; 67(3):209-14. PubMed ID: 22530301
[TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo evaluation of silybin nanosuspensions for oral and intravenous delivery.
Wang Y; Zhang D; Liu Z; Liu G; Duan C; Jia L; Feng F; Zhang X; Shi Y; Zhang Q
Nanotechnology; 2010 Apr; 21(15):155104. PubMed ID: 20332565
[TBL] [Abstract][Full Text] [Related]
10. [Studies on preparation of recombinant hirudin-2 liposome and its pharmacokinetics by nasal delivery in rats].
Zhang YJ; Wang XL; Wu JM; Cheng MX
Zhongguo Zhong Yao Za Zhi; 2007 May; 32(9):801-4. PubMed ID: 17639978
[TBL] [Abstract][Full Text] [Related]
11. Binary lipids-based nanostructured lipid carriers for improved oral bioavailability of silymarin.
Shangguan M; Lu Y; Qi J; Han J; Tian Z; Xie Y; Hu F; Yuan H; Wu W
J Biomater Appl; 2014 Feb; 28(6):887-96. PubMed ID: 24008629
[TBL] [Abstract][Full Text] [Related]
12. Silymarin glyceryl monooleate/poloxamer 407 liquid crystalline matrices: physical characterization and enhanced oral bioavailability.
Lian R; Lu Y; Qi J; Tan Y; Niu M; Guan P; Hu F; Wu W
AAPS PharmSciTech; 2011 Dec; 12(4):1234-40. PubMed ID: 21948306
[TBL] [Abstract][Full Text] [Related]
13. Oral bioavailability of silymarin formulated as a novel 3-day delivery system based on porous silica nanoparticles.
Cao X; Fu M; Wang L; Liu H; Deng W; Qu R; Su W; Wei Y; Xu X; Yu J
Acta Biomater; 2012 Jul; 8(6):2104-12. PubMed ID: 22343518
[TBL] [Abstract][Full Text] [Related]
14. Reassessing bioavailability of silymarin.
Javed S; Kohli K; Ali M
Altern Med Rev; 2011 Sep; 16(3):239-49. PubMed ID: 21951025
[TBL] [Abstract][Full Text] [Related]
15. Preparation and Characterization of Silymarin Synchronized and Sustained Release Dropping Pill.
Liu ZH; Li XJ; Huang AW; Zhang J; Song HT
Curr Drug Deliv; 2017; 14(5):650-657. PubMed ID: 28201965
[TBL] [Abstract][Full Text] [Related]
16. A New Type of Liquid Silymarin Proliposome Containing Bile Salts: Its Preparation and Improved Hepatoprotective Effects.
Wang M; Xie T; Chang Z; Wang L; Xie X; Kou Y; Xu H; Gao X
PLoS One; 2015; 10(12):e0143625. PubMed ID: 26674103
[TBL] [Abstract][Full Text] [Related]
17. In vivo absorption comparison of nanotechnology-based silybin tablets with its water-soluble derivative.
Xu D; Ni R; Sun W; Li LC; Mao S
Drug Dev Ind Pharm; 2015 Apr; 41(4):552-9. PubMed ID: 24495272
[TBL] [Abstract][Full Text] [Related]
18. Bioavailability of a silybin-phosphatidylcholine complex in dogs.
Filburn CR; Kettenacker R; Griffin DW
J Vet Pharmacol Ther; 2007 Apr; 30(2):132-8. PubMed ID: 17348898
[TBL] [Abstract][Full Text] [Related]
19. Formulation optimization of self-emulsifying preparations of puerarin through self-emulsifying performances evaluation in vitro and pharmacokinetic studies in vivo.
Quan DQ; Xu GX
Yao Xue Xue Bao; 2007 Aug; 42(8):886-91. PubMed ID: 17944241
[TBL] [Abstract][Full Text] [Related]
20. [Preparation of puerarin liposome and its oral absorption in rat].
Gu YZ; Zhou W; Zhai GX
Zhong Yao Cai; 2007 Aug; 30(8):970-3. PubMed ID: 18074848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
